Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 7/20 | 0.61 |
| ▸ | DYRK1A | Q13627 | 7/20 | 0.61 |
| ▸ | ABL1 | P00519 | 8/20 | 0.44 |
| ▸ | WNT1 | P04628 | 2/20 | 0.41 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | TYK2 | P29597 | 1/20 | 0.39 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4302469 | 0.84 | GSK3B (0.61) | GSK3BDYRK1AABL1WNT1 | |
| SCHEMBL29650022 | 0.84 | GSK3B (0.61) | GSK3BDYRK1AABL1WNT1 | |
| SCHEMBL28166698 | 0.83 | GSK3B (0.60) | GSK3BDYRK1AABL1SYKNOTUM | |
| SCHEMBL30636341 | 0.83 | GSK3B (0.60) | GSK3BDYRK1AABL1SYKNOTUM | |
| SCHEMBL17631721 | 0.83 | DYRK1A (0.60) | GSK3BDYRK1AABL1WNT1MAPK1 | |
| SCHEMBL29710311 | 0.83 | DYRK1A (0.60) | GSK3BDYRK1AABL1WNT1MAPK1 | |
| SCHEMBL29710317 | 0.83 | DYRK1A (0.60) | GSK3BDYRK1AABL1WNT1MAPK1 | |
| SCHEMBL17631521 | 0.82 | GSK3B (0.59) | GSK3BDYRK1AABL1WNT1 | |
| SCHEMBL17643975 | 0.81 | DYRK1A (0.58) | GSK3BDYRK1AABL1WNT1 | |
| SCHEMBL29993248 | 0.81 | DYRK1A (0.58) | GSK3BDYRK1AABL1WNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001339-A | Novel compounds | 特殊治疗有限公司 | 2017-08-01 | — | — | CN | disclosed |